Early Parkinson’s signs found in blood
Early biological signs of Parkinson’s disease have been detected in [...]
Epilepsy drug firm secures US$2.4m grants
An epilepsy drug firm has secured US$2.4m in grant funding [...]
UK neurotech investment doubled since 2024, MHRA says
Investment in UK neurotechnology studies has doubled since 2024, now [...]
Biotech closes $200m private placement to trial MS drug
Immunic has closed a private placement raising US$200m upfront to [...]
Paracetamol may increase stroke risk, study suggests
Regular use of paracetamol may increase the risk of stroke [...]
Biotech names lead Huntington’s drug candidate
Harness Therapeutics has named HRN001 as its lead Huntington’s disease [...]
Depression may indicate future Parkinson’s diagnosis, study suggests
Depression can appear years before a diagnosis of Parkinson’s disease [...]
Depression symptoms improve after single DMT dose, study finds
A single dose of DMT given alongside psychotherapy has been [...]
Wellumio raises $6.2m in pre-Series A first close
A New Zealand medtech developing a portable scanner to detect [...]
New clinic launched to support younger stroke survivors
A new clinic has been launched to support younger stroke [...]
